One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Surgical Sutures Market

[ 英語タイトル ] Surgical Sutures Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083210
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - B. Braun Mesungen AG
- Boston Scientific Corporation
- Conmed Corporation
- Integra LifeSciences Corporation
- Johnson & Johnson
- Medtronic PLC
- Mellon Medical B.V.
- Smith & Nephew PLC
- Teleflex Incorporated

[Report Description]

A suture refers to any strand of material that is used to litigate blood vessels or tissues to close a surgical site. The type of material used primarily decides the level of sutures layers be done by a specialty doctor. One of the primary factors responsible for the increased sutures usage and its adoption is the rise in the hospital admission of chronic disease patients for long term as well as increased trauma cases across developed and emerging markets. In a large number of orthopedic, alimentary, ophthalmic cases and several other parts of the body require surgical suturing in case of surgeries. A large number of hospitals and ambulatory surgery departments are specializing and technologically advancing in surgical sutures techniques which further drive this market. However, with growth in personalized medications, there is growth in usage of minimally invasive procedures as well as in many cases, needle-related infections primarily hinder the growth rate of the surgical sutures market, over the forecast period.

Key Market Trends

The Absorbable Sutures are Estimated to Hold Larger Share over the Forecast Period

The absorbable sutures are highly useful in the treatment of inner organ surgical site closure. The natural sore and synthetic sources have their advantages based upon the areas of the body to be used upon. They generally degrade in the soft tissues within 60 days or more based upon absorbable or non-absorbable character. Since the source is collagen, copolymer, and polyester polymers, which are widely available and manufactured easily, the adoption rate and usage are much faster than non-absorbable. Furthermore, with the increasing number of surgeries and rising lifestyle diseases, such as obesity, diabetes, heart disease, and stroke, this segment of the market is expected to witness good growth.

North America is Expected to Have Largest Share in the Global Market

In the United States, high admission rates, technological advancements in healthcare facilities, more healthcare expenditure from the government as well as better distribution channels by companies as well as reimbursement policies drives the surgical sutures market. Medical tourism from several emerging market also drives the growth of this market. However, with rising personalized medications, the trend is expected to shift towards minimally invasive surgeries, which may decrease the usage of surgical sutures rates gradually over the forecast period. Canada also well-known for its better government policies and medical tourism as well as technical advantages in healthcare compared to several emerging markets. Therefore, North America is expected to hold a major share of the studied market, over the forecast period.

Competitive Landscape

The major market players are focusing on technological advancements and improving the material quality used in sutures and better treatment of the injury site. Some of the major players in the market are B Braun Mesungen AG, Johnson & Johnson, Smith & Nephew PLC, Teleflex Incorporated, Integra LifeSciences, among others.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Surgeries Owing to Unhealthy Lifestyle and Chronic Diseases
4.2.2 Technological Advances in Suture Design and Applications
4.2.3 Favourable Government Regulations
4.3 Market Restraints
4.3.1 Needle related infections
4.3.2 Increasing Preference Towards Minimally Invasive Surgery
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Absorbable Sutures Natural Sutures Synthetic Sutures
5.1.2 Non-absorbable Sutures Nylon Prolene Other Non-absorbable Sutures
5.2 By Application
5.2.1 Ophthalmic Surgery
5.2.2 Cardiovascular Surgery
5.2.3 Orthopedic Surgery
5.2.4 Neurological Surgery
5.2.5 Other Applications
5.3 By End-user
5.3.1 Hospitals/Clinics
5.3.2 Ambulatory Surgical Centers
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 B. Braun Mesungen AG
6.1.2 Boston Scientific Corporation
6.1.3 Conmed Corporation
6.1.4 Integra LifeSciences Corporation
6.1.5 Johnson & Johnson
6.1.6 Medtronic PLC
6.1.7 Mellon Medical B.V.
6.1.8 Smith & Nephew PLC
6.1.9 Teleflex Incorporated




Recommended reports